Characterization of Heparin-induced Glyceraldehyde-3-phosphate Dehydrogenase Early Amyloid-like Oligomers and Their Implication in alpha-Synuclein Aggregation


Autoria(s): Torres-Bugeau, Clarisa M.; Avila, Cesar L.; Raisman-Vozari, Rita; Papy-Garcia, Dulce; Itri, Rosangela; Barbosa, Leandro Ramos Souza; Cortez, Leonardo M.; Sim, Valerie L.; Chehin, Rosana N.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

07/11/2013

07/11/2013

2012

Resumo

Lewy bodies and Lewy neurites, neuropathological hallmarks of several neurological diseases, are mainly made of filamentous assemblies of alpha-synuclein. However, other macromolecules including Tau, ubiquitin, glyceraldehyde-3-phosphate dehydrogenase, and glycosaminoglycans are routinely found associated with these amyloid deposits. Glyceraldehyde-3-phosphate dehydrogenase is a glycolytic enzyme that can form fibrillar aggregates in the presence of acidic membranes, but its role in Parkinson disease is still unknown. In this work, the ability of heparin to trigger the amyloid aggregation of this protein at physiological conditions of pH and temperature is demonstrated by infrared and fluorescence spectroscopy, dynamic light scattering, small angle x-ray scattering, circular dichroism, and fluorescence microscopy. Aggregation proceeds through the formation of short rod-like oligomers, which elongates in one dimension. Heparan sulfate was also capable of inducing glyceraldehyde-3-phosphate dehydrogenase aggregation, but chondroitin sulfates A, B, and C together with dextran sulfate had a negligible effect. Aided with molecular docking simulations, a putative binding site on the protein is proposed providing a rational explanation for the structural specificity of heparin and heparan sulfate. Finally, it is demonstrated that in vitro the early oligomers present in the glyceraldehyde-3-phosphate dehydrogenase fibrillation pathway promote alpha-synuclein aggregation. Taking into account the toxicity of alpha-synuclein prefibrillar species, the heparin-induced glyceraldehyde-3-phosphate dehydrogenase early oligomers might come in useful as a novel therapeutic strategy in Parkinson disease and other synucleinopathies.

Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 2518]

Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)

Consejo Investigaciones de la Universidad Nacional de Tucuman (CIUNT) [26/D439-1]

Consejo Investigaciones de la Universidad Nacional de Tucuman (CIUNT)

Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)

Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)

Identificador

JOURNAL OF BIOLOGICAL CHEMISTRY, BETHESDA, v. 287, n. 4, supl. 1, Part 1, pp. 2398-2409, 43831, 2012

0021-9258

http://www.producao.usp.br/handle/BDPI/42835

10.1074/jbc.M111.303503

http://dx.doi.org/10.1074/jbc.M111.303503

Idioma(s)

eng

Publicador

AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC

BETHESDA

Relação

JOURNAL OF BIOLOGICAL CHEMISTRY

Direitos

closedAccess

Copyright AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC

Palavras-Chave #X-RAY-SCATTERING #PARKINSONS-DISEASE #FIBRIL FORMATION #FILAMENTOUS INCLUSIONS #MOONLIGHTING PROTEINS #INFRARED-SPECTROSCOPY #ALZHEIMERS-DISEASE #LEWY BODIES #BETA #GLYCOSAMINOGLYCANS #BIOCHEMISTRY & MOLECULAR BIOLOGY
Tipo

article

original article

publishedVersion